Mostrar el registro sencillo del ítem

dc.creatorOchoa-Morales, Adrianaes_ES
dc.creatorFresan-Orellana, Anaes_ES
dc.creatorRamírez-García, Miguel Ángeles_ES
dc.creatorMárquez-González, Horacioes_ES
dc.creatorMartínez-Juárez, Iris E.es_ES
dc.creatorLópez-Uribe, Mayraes_ES
dc.creatorZuniga-García, Caroles_ES
dc.creatorJara-Prado, Aurelioes_ES
dc.creatorGuerrero-Camacho, Jorge Luises_ES
dc.creatorDávila-Ortiz de Montello, David Josées_ES
dc.date2023
dc.date.accessioned2025-03-28T19:16:50Z
dc.date.available2025-03-28T19:16:50Z
dc.date.issued2023
dc.identifierJC62es_ES
dc.identifier.issn1525-5050
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/8279
dc.identifier.urihttps://doi.org/10.1016/j.yebeh.2023.109268
dc.descriptionBackground: People with epilepsy (PWE) have been subject to stigma throughout history, a factor that could compromise their performance in daily life. In Mexico, little is known about the factors that may be affecting internalized stigma. Objective: To evaluate the internalized stigma in adult PWE, its relationship with the quality of life, cognitive and depressive symptomatology, and clinical-demographic characteristics. Material and methods: We conducted a cross-sectional study with a consecutive sampling approach in patients with epilepsy treated at the National Institute of Neurology and Neurosurgery Manuel Velasco Suárez (NINNMVS). Sociodemographic and clinical data, depressive symptomatology (Beck's depression inventory, DBI), cognition (MoCA test), quality of life (QOLIE-31 scale), and internalized stigma (King's internalized stigma scale, ISS) were evaluated. Correlations were made between the continuous variables and the ISS to select those with statistical significance and include them in a multiple linear regression model, along with the dummy variables, to explain internalized stigma. Results: Of 128 patients, 74 (58%) were women; 38% of the patients had more than 20 years of epilepsy evolution. In addition, 39% presented depressive symptoms, and around 60% manifested a possible cognitive impairment. The variables that showed statistical significance concerning the ISS were selected along with dummy variables for multiple linear regression analysis. The resultant model considers the QOLIE-31 total score (β = -0.489), the number of anti-seizure drugs (ASD, β = 0.253), and those patients without caregiver support (β = -0.166) with an adjusted R2 value of 0.316. Conclusions: A diminishing quality of life, an increased number of ASD, and patients without caregiver support influence a slight to moderate variation of internalized stigma in Mexican PWE. Therefore, it is necessary to continue studying other possible factors that influence internalized stigma to generate effective strategies to reduce its negative effects on PWE.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherAcademic Presses_ES
dc.relation144:109268
dc.rightsAcceso Cerradoes_ES
dc.titleLow quality of life, increased number of anti-seizure drugs, and the lack of caregiver support are associated with internalized stigma in adult Mexican patients with epilepsyes_ES
dc.typeArtículoes_ES
dc.contributor.affiliationGenetics Department. National Institute of Neurology and Neurosurgery, Manuel Velasco Suárez, Mexico City, Mexico
dc.contributor.emaildavid.montellano@innn.edu.mx (D.J. Dávila-Ortiz de Montellano)
dc.relation.jnabreviadoEPILEPSY BEHAV
dc.relation.journalEpilepsy & Behavior
dc.identifier.placeEstados Unidos
dc.date.published2023
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.eissn1525-5069
dc.identifier.doi10.1016/j.yebeh.2023.109268
dc.subject.kwInternalized Stigma
dc.subject.kwEpilepsy
dc.subject.kwQOLIE-31
dc.subject.kwDepressive Symptoms
dc.subject.kwAnti-seizure drugs


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem